Evidence map›Paper›PMID 36895289›Full record

ArticleJournal of hematology2023

Transformed Plasmablastic Lymphoma Presenting With Marked Lymphocytosis and Spontaneous Tumor Lysis Syndrome.

Yannis Hadjiyannis, Cecelia Miller, Norris I Hollie, Jayalakshmi Balakrishna, Francesca Cottini

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yannis HadjiyannisDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.ORCID https://orcid.org/0000-0001-6723-4299
Cecelia MillerDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Columbus, OH 43201, USA.
Norris I HollieDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Columbus, OH 43201, USA.
Jayalakshmi BalakrishnaDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Columbus, OH 43201, USA.
Francesca CottiniDivision of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43201, USA.ORCID https://orcid.org/0000-0001-8676-7840
The Ohio State University Wexner Medical Center · USThe Ohio State University · USUniversity of Pittsburgh Medical Center · US

Funding

Investigating CD56 signaling in multiple myeloma growth and immune escapeK08CA263476 · NCI · OHIO STATE UNIVERSITY · PI Francesca Cottini · 2022 to 2026
$1.3M
NCI NIH HHS K08 CA263476
6 · The paper itself

Abstract

The clinicopathology entity of plasmablastic lymphoma (PBL), despite broad recognition by the World Health Organization (WHO), represents a diagnostic challenge due to its overlapping features and scarce occurrence. Often, PBL arises in immunodeficient, elderly male patients, most notably those who are human immunodeficiency virus (HIV)-positive. More infrequent, cases of transformed PBL (tPBL) evolved from another hematologic disease have been identified. Herein, we describe a case of a 65-year-old male transferred from a neighboring hospital with pronounced lymphocytosis and spontaneous tumor lysis syndrome (sTLS) presumed to be chronic lymphocytic leukemia (CLL). Utilizing a complete clinical, morphologic, immunophenotypic, and molecular evaluation, we arrived at a final diagnosis of tPBL with sTLS, suspected to have evolved from the

Indexed as

Double-hit lymphomaEBVPlasmablastic lymphomaSplenic marginal zone lymphomaTumor lysis syndrome

Identifiers

PMID36895289
PMCPMC9990712
OpenAlexW4321850969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.